Text Size

Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre

This study has been completed.
Sponsor:
Collaborator:
Hôpital Gériatrique Les Bateliers, CHRU Lille
Information provided by (Responsible Party):
Centre Oscar Lambret
ClinicalTrials.gov Identifier:
NCT01415258
First received: August 10, 2011
Last updated: May 15, 2012
Last verified: May 2012
History of Changes

August 10, 2011
May 15, 2012
March 2011
August 2011   (final data collection date for primary outcome measure)
To assess the Vulnerable Elders Survey score (VES-13) [ Time Frame: Within 3 months after recruitment ] [ Designated as safety issue: No ]
A patient is identified vulnerable if the score is ≥ 3
Same as current
Complete list of historical versions of study NCT01415258 on ClinicalTrials.gov Archive Site
  • To assess the correlation between the VES-13 score and the vulnerability judged by a clinical expert [ Time Frame: Within 3 months after recruitment ] [ Designated as safety issue: No ]
    A patient will be identified as vulnerable if he/she belongs to the "intermediate" or "frail" category. The Kappa coefficient of agreement will be used to correlate the VES-13 score and clinical observations.
  • To measure the muscle strength using the grip strength test [ Time Frame: Within 3 months after recruitment ] [ Designated as safety issue: No ]
    Hand Dynamometer Range values : 0-90
Same as current
Not Provided
Not Provided
 
Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre
Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre

The objective of this study is to uncover the prevalence of vulnerability among patients aged ≥ 70 coming to the medical oncology division of the Oscar Lambret Centre, according to the short screening test Vulnerable Elders Survey 13 (VES-13).

The objective is to better understand the value of routine screening of patients before the consultation, it was proposed as a secondary objective of this study to assess the correlation between the identification of the vulnerability in the screening test VES-13 and the identification made ​​by the clinician during the consultation. The correlation between VES-13 and opinion of the clinician for three categories of patients (self - intermediate - fragile) will also be studied.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

This study concerns elderly patients (≥70 years) with solid tumors
Solid Tumor
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
209
April 2012
August 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • patient aged ≥ 70
  • coming for a first visit, whatever the purpose and the disease stage

Exclusion Criteria:

  • neglect or refusal to answer to the VES-13 test
Both
70 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01415258
VULNERABILITE-1103
No
Centre Oscar Lambret
Centre Oscar Lambret
Hôpital Gériatrique Les Bateliers, CHRU Lille
Principal Investigator: Véronique SERVENT, MD Oscar Lambret Anti-Cancer Centre
Centre Oscar Lambret
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP